Health Condition 1: F321- Major depressive disorder, singleepisode, moderate
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. The patients to have met the DSM-V diagnostic criteria for MDD (will be assessed by the referring clinician). 2. In this study only mild to moderate cases of depression will be taken 3. Age range from 20-50 years 4. Patients of both sex (male & female) will be included 3
Exclusion criteria
Exclusion criteria: ? Patients with symptoms or having the history of following clinical condition will be excluded. 1. Depression with comorbid serious somatic illness, e.g., myocardial infarction, multiple sclerosis, cerebral stroke, hypothyroidism and cancer etc. 2. Drug or alcohol dependence related depression. 3. Pregnancy related depression, postpartum depression, postnatal depression etc. 4. Depression with psychotic symptoms e.g. delusion or hallucinations, incoherence, marked loosening of associations etc. 5. Patients with history of diabetes and severe hypertension
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Symptomatic Grading, 2. HDRS (HAMILTON DEPRESSION RATING SCALE) Scale 3. WHO quality of life. Timepoint: Before Treatment (BT), After one month (F1), after two months (F2), and after three months of Clinical Trial (AT) | — |
Secondary
| Measure | Time frame |
|---|---|
| positive & promotive improvement in the mental health.Timepoint: 90 days | — |
Countries
India
Contacts
Institute of Medical Science, Banaras Hindu University Varanasi UP